Dose range finding and main efficacy study for one peptide-drug-conjugate using the MDA-MB-231 cell line-based xenograft mouse model of triple negative breast cancer (2022-2024)
Experts
Emeritus Professor
Maree Smith
Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR)